Spots Global Cancer Trial Database for follicular thyroid cancer
Every month we try and update this database with for follicular thyroid cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Aberrant Helix Pomatia Agglutinin Binding Glycan Expression in Follicular Thyroid Tumours | NCT05052359 | Follicular Thyr... | Lectin-histoche... | 18 Years - | National University Health System, Singapore | |
| Psychological Impact of a Sophrological Accompaniment During the Announcement of Thyroid Cancer | NCT03639662 | Follicular Thyr... | sophrology sess... | 18 Years - | Assistance Publique Hopitaux De Marseille | |
| PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer | NCT04544111 | Thyroid Cancer Thyroid Cancer,... Papillary Thyro... Follicular Thyr... Hurthle Cell Tu... Poorly Differen... Hurthle Cell Th... | Trametinib Dabrafenib PDR001 | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Urinary Exosomal Biomarkers of Thyroglobulin and Galectin-3 for Prognosis and Follow-up in Patients of Thyroid Cancer | NCT04948437 | Thyroid Cancer Papillary Thyro... Follicular Thyr... | 20 Years - 80 Years | National Taiwan University Hospital | ||
| A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid Cancer | NCT00121628 | Thyroid Cancer | AMG 706 | 18 Years - | Amgen | |
| Sutent Adjunctive Treatment of Differentiated Thyroid Cancer | NCT00668811 | Papillary Thyro... Follicular Thyr... Differentiated ... | SU011248, Suten... | 18 Years - | Medstar Health Research Institute | |
| A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen. | NCT00295763 | Differentiated ... | Thyrogen (thyro... | 18 Years - | Sanofi | |
| A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid Tumors | NCT01100619 | Papillary Thyro... Follicular Thyr... Huerthle Cell T... Renal Cell Carc... | rosiglitazone XL184 | 18 Years - | Exelixis | |
| Testicular Function After Iodine 131 Therapy in Papillary Carcinoma Patients | NCT01150318 | Thyroid Neoplas... | Administration ... | 18 Years - 55 Years | Assistance Publique - Hôpitaux de Paris | |
| A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen. | NCT00295763 | Differentiated ... | Thyrogen (thyro... | 18 Years - | Sanofi | |
| Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer | NCT03630120 | Thyroid Cancer Thyroid Cancer,... Differentiated ... Papillary Thyro... Follicular Thyr... Poorly Differen... | Lenvatinib Sorafenib Cabozantinib Vandetanib | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Studies on Tumors of the Thyroid | NCT00001160 | Hurthle Cell Th... Tall Cell Varia... Follicular Thyr... Thyroid Cancer Papillary Thyro... | 68-Gallium Dota... | 6 Months - 98 Years | National Institutes of Health Clinical Center (CC) | |
| PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer | NCT04544111 | Thyroid Cancer Thyroid Cancer,... Papillary Thyro... Follicular Thyr... Hurthle Cell Tu... Poorly Differen... Hurthle Cell Th... | Trametinib Dabrafenib PDR001 | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC | NCT05668962 | Thyroid Cancer Thyroid Carcino... Metastatic Thyr... Follicular Thyr... Unresectable Th... Papillary Thyro... | Selpercatinib Sodium Iodine I... rhTSH | 12 Years - | Massachusetts General Hospital | |
| Aberrant Helix Pomatia Agglutinin Binding Glycan Expression in Follicular Thyroid Tumours | NCT05052359 | Follicular Thyr... | Lectin-histoche... | 18 Years - | National University Health System, Singapore | |
| Metabolic Effects of Synthetic Thyroid Hormone for Thyroid Cancer Treatment | NCT01441154 | Malignant Strum... Papillary Thyro... Hurthle Cell Th... Follicular Thyr... Tall Cell Varia... | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | ||
| A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen. | NCT00295763 | Differentiated ... | Thyrogen (thyro... | 18 Years - | Sanofi | |
| Correlation Between Various Urinary Exosomal Protein Biomarkers and Pathological Manifestation in Thyroid Follicular Neoplasm: Early and Pre-operative Diagnosis of Follicular Thyroid Cancer | NCT05463107 | Thyroid Cancer Follicular Thyr... | 20 Years - 80 Years | National Taiwan University Hospital | ||
| A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy | NCT03690388 | Differentiated ... | Cabozantinib Placebo | 16 Years - | Exelixis | |
| Testicular Function After Iodine 131 Therapy in Papillary Carcinoma Patients | NCT01150318 | Thyroid Neoplas... | Administration ... | 18 Years - 55 Years | Assistance Publique - Hôpitaux de Paris |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
